期刊文献+

益气化瘀方治疗2型糖尿病下肢动脉闭塞临床观察 被引量:2

Clinical observation of “Yiqi Huayu Decoction ” for the treatment of type 2 diabetic arterial occlusion of lower extremities
下载PDF
导出
摘要 目的观察益气化瘀方治疗2型糖尿病下肢动脉闭塞症(DAO)的临床疗效。方法将60例DAO患者随机分为治疗组和对照组,各30例;两组均给予常规西药治疗以控制血糖,治疗组同时服用益气化瘀方,疗程12周。治疗前后分别用多普勒超声检测患者下肢动脉内径和收缩期最大血流速度。结果治疗后两组患者下肢各动脉内径均较治疗前明显增宽(P<0.05),且治疗组各动脉内径较对照组增宽(P<0.05);两组患者下肢各动脉血流速度均较治疗前明显增快(P<0.05),且治疗组各动脉血流速度较对照组增快(P<0.05)。结论益气化瘀方能明显改善2型糖尿病患者下肢动脉硬化闭塞症。 Objective To observe the clinical efficacy of " Yiqi Huayn Decoction" in the treatment of type 2 diabetic arterial occlusion (DAO) of lower extremities. Methods Sixty cases with DAO were randomized into treatment group and control group, with 30 cases in each group. Both of the groups were treated by conventional western medicine to control blood glucose. Additionally, treatment group was treated with " Yiqi Huayu Decoction", with the course of 12 weeks. The inner diameter and maximum blood flow velocity of lower extremity vessels were detected by color Doppler image before and after treatment. Results After treatment, the inner diameter of lower extremity vessels were obviously dilated in both groups ( P 〈 0.05 ), with more significant dilation in the treatment group than that of the control group ( P 〈 0.05 ). After" treatment, the blood flow velocity increased obviously in both groups ( P 〈 0.05 ), with significant difference between the two groups ( P 〈 0.05 ). Conclusion "Yiqi Huayu Decoction" is effective for type 2 diabetic arterial occlusion of lower extremities.
出处 《上海中医药杂志》 2014年第4期57-58,61,共3页 Shanghai Journal of Traditional Chinese Medicine
关键词 糖尿病 下肢动脉闭塞症 益气化瘀方 diabetes mellitus arterial occlusion of lower extremities "Yiqi Huayu Decoction"
  • 相关文献

参考文献5

二级参考文献25

  • 1王海波,王章元.蒲黄药理作用的研究进展[J].医药导报,2005,24(4):318-319. 被引量:52
  • 2何燕铭,王文健,陈伟华,应健,何春燕,马宇滢,刘毅,李佑生.蒲黄总黄酮对3T3-L1脂肪细胞糖脂代谢的影响[J].中西医结合学报,2006,4(6):593-595. 被引量:30
  • 3刘成玉,滕青,谭润鸾.NIDDM 血管病变与人巨细胞病毒感染关系的研究[J].中国糖尿病杂志,1997,5(2):108-109. 被引量:4
  • 4Ram ji DP, Foka P. CCAAT/enhancer-binding proteins:structure, function and regulation. Biochem J 2002; 365:561-575.
  • 5Bloomgarden ZT. Obesity, hypertension, and insulin resistance. Diabetes Care 2002 ;25 ( 11 ): 2088-2097.
  • 6Atsuko Takano, Tetsuro Haruta, Minoru lwata, et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes. Diabetes 2001;50:1981-1900.
  • 7Rosen ED, Hus CH, Wang X, et al. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev2002; 16: 22-26.
  • 8Wilding JP. The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med. 2007; 24 (9) : 934 -945.
  • 9Takano A, Haruta induces cellular phosphatidylinositol 3T3- L1 adipocytes. T, Iwata M, el al. Growth hormone insulin resistance by uncoupling 3 kinase and its downstream signals in Diabetes. 2001; 50(8) : 1891-1900.
  • 10Chou FS, Wang PS, Kulp S. Effects of thiazolidinediones on differentiation, proliferation, and apoptosis. MolCancer Res. 2007; 5(6): 523- 530.

共引文献200

同被引文献18

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部